=========================================================================

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION  
Washington, DC 20549

FORM 10-QSB



|[ x ]   | Quarterly Report Pursuant to Section 13 or 15(d) of the Securities  Exchange Act of 1934
|------- | ----------------------------------------------------------------------------------------
|        | FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2004                                       
|        |                                                                                         
|OR      |                                                                                         
|        |                                                                                         
|[     ] | Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
|        | For the transition period from ________ to ________                                     

Commission File Number:   000-27094

FIRST AMERICAN SCIENTIFIC CORP.



|NEVADA                                                         | 88-0338315                          
|-------------------------------------------------------------- | ------------------------------------
|(State of other jurisdiction of incorporation or organization) | (IRS Employer Identification Number)

100 Park Royal South 
Suite 811 
Vancouver, British Columbia 
Canada  V7T 1A2(Address of principal executive offices)

(604) 913-9035 (Registrant's telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.   Yes [ x ]   No [      ]

=========================================================================

---

PART I.

ITEM 1.   FINANCIAL STATEMENTS

FIRST AMERICAN SCIENTIFIC CORP.

TABLE OF CONTENTS



|                                          
|------------------------------------------
|FINANCIAL STATEMENTS                      
|                                          
|                                          
|                                          
|                                          
|                                          
|NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
|                                          























-2-

---



|FIRST AMERICAN SCIENTIFIC CORP.
CONSOLIDATED BALANCE SHEETS
|-----------------------------------------------------------
|                                                           
|                                                           
|ASSETS                                                     
|                                                           
|CURRENT ASSETS                                             
|                                                           
|                                                           
|                                                           
|                                                           
|                                                           
|                                                           
|PROPERTY AND EQUIPMENT                                     
|                                                           
|                                                           
|                                                           
|                                                           
|OTHER ASSETS                                               
|                                                           
|                                                           
|                                                           
|                                                           
|                                                           
|TOTAL ASSETS                                               
|                                                           
|LIABILITIES AND STOCKHOLDERS' EQUITY                       
|                                                           
|CURRENT LIABILITIES                                        
|                                                           
|                                                           
|                                                           
|                                                           
|LONG-TERM LIABILITIES                                      
|                                                           
|                                                           
|                                                           
|COMMITMENTS AND CONTINGENCIES                              
|                                                           
|STOCKHOLDERS' EQUITY                                       
|                                                           
|                                                           
|                                                           
|                                                           
|                                                           
|                                                           
|                                                           
|                                                           
|                                                           
|TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY                 

See accompanying condensed notes to interim financial statements.

F-1

-3-

---



|FIRST AMERICAN SCIENTIFIC CORP.
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS)
|-----------------------------------------------------------------------------------------------------
|                                                                                                     
|
|                                                                                                     
|                                                                                                     
|                                                                                                     
|REVENUES                                                                                             
|                                                                                                     
|COST OF SALES                                                                                        
|                                                                                                     
|GROSS PROFIT                                                                                         
|                                                                                                     
|OPERATING EXPENSES                                                                                   
|                                                                                                     
|                                                                                                     
|                                                                                                     
|                                                                                                     
|                                                                                                     
|                                                                                                     
|                                                                                                     
|                                                                                                     
|                                                                                                     
|                                                                                                     
|INCOME (LOSS) BEFORE INCOME TAXES                                                                    
|                                                                                                     
|INCOME TAXES                                                                                         
|                                                                                                     
|NET INCOME (LOSS) BEFORE ALLOCATION TO MINORITY INTEREST                                             
|                                                                                                     
|ALLOCATION OF LOSS TO MINORITY INTEREST                                                              
|                                                                                                     
|NET INCOME (LOSS)                                                                                    
|                                                                                                     
|OTHER COMPREHENSIVE INCOME (LOSS)                                                                    
|                                                                                                     
|                                                                                                     
|COMPREHENSIVE NET INCOME (LOSS)                                                                      
|                                                                                                     
|                                                                                                     
|                                                                                                     
|                                                                                                     
|                                                                                                     
|                                                                                                     

See accompanying condensed notes to interim financial statements.

F-2

-4-

---



|FIRST AMERICAN SCIENTIFIC CORP.
CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY
|------------------------------------------------------------------------------
|                                                                              
|                                                                              
|                                                                              
|                                                                              
|                                                                              
|Balance, July 1, 2003                                                         
|                                                                              
|Common stock issued for cash at $0.04 per share                               
|                                                                              
|Options issued for expenses, compensation &                                   
|consulting                                                                    
|                                                                              
|Common stock issued and exercise of options for                               
|                                                                              
|                                                                              
|Common stock issued as repayment of debt                                      
|                                                                              
|Common stock issued for services at $0.048 per                                
|share                                                                         
|                                                                              
|Common stock issued for services at $0.05 per                                 
|share                                                                         
|                                                                              
|Common stock issued and options exercised as                                  
|                                                                              
|                                                                              
|Common stock issued for rent expense at $0.05                                 
|per share                                                                     
|                                                                              
|Common stock issued in payment of financing                                   
|                                                                              
|                                                                              
|Foreign currency translation loss                                             
|                                                                              
|Net loss for the year ended June 30, 2004                                     
|                                                                              
|Balance, June 30, 2004                                                        
|                                                                              
|Common stock issued for cash at approximately $0.07 per share                 
|                                                                              
|Common stock issued for compensation and other                                
|                                                                              
|                                                                              
|                                                                              
|Foreign currency translation loss                                             
|                                                                              
|Net loss for the period ended September 30, 2004                              
|(unaudited)                                                                   
|                                                                              
|Balance, September 30, 2004 (unaudited)                                       

See accompanying condensed notes to interim financial statements.

F-3

-5-

---



|FIRST AMERICAN SCIENTIFIC CORP.
CONSOLIDATED STATEMENTS OF CASH FLOWS
|---------------------------------------------------------------------
|                                                                     
|                                                                     
|                                                                     
|CASH FLOWS PROVIDED (USED) IN OPERATING ACTIVITIES                   
|                                                                     
|                                                                     
|                                                                     
|                                                                     
|                                                                     
|                                                                     
|                                                                     
|                                                                     
|                                                                     
|                                                                     
|                                                                     
|                                                                     
|                                                                     
|                                                                     
|                                                                     
|                                                                     
|Net cash (used) in operating activities                              
|                                                                     
|CASH FLOWS PROVIDED (USED) IN INVESTING ACTIVITIES                   
|                                                                     
|Net cash provided by investing activities                            
|                                                                     
|CASH FLOWS PROVIDED (USED) IN FINANCING ACTIVITIES                   
|                                                                     
|                                                                     
|Net cash provided (used) by financing activities                     
|                                                                     
|NET INCREASE (DECREASE) IN CASH                                      
|                                                                     
|Other comprehensive income (loss)                                    
|                                                                     
|CASH - Beginning of year                                             
|                                                                     
|CASH - End of period                                                 
|                                                                     
|SUPPLEMENTAL CASH FLOW DISCLOSURES:                                  
|                                                                     
|                                                                     
|                                                                     
|NON-CASH TRANSACTIONS:                                               
|Common stock issued for services and compensation                    
|Stock issued for expenses                                            
|Stock issued for services and current debt                           

See accompanying condensed notes to interim financial statements.

F-4

-6-

---

FIRST AMERICAN SCIENTIFIC CORP.
Notes to Consolidated Financial Statements
September 30, 2004

______________________________________________________________________________________________

NOTE 1 - BASIS OF PRESENTATION

The foregoing unaudited interim financial statements of First American Scientific Corp. (hereinafter "FASC" or "the Company") have been prepared in accordance with generally accepted accounting principles for interim financial information and with the instructions to Form 10-QSB and Regulation S-B as promulgated by the Securities and Exchange Commission ("SEC").  Accordingly, these financial statements do not include all of the disclosures required by generally accepted accounting principles in the United States of America for complete financial statements.  These unaudited interim financial statements should be read in conjunction with the audited financial statements for the year ended June 30, 2004.  In the opinion of management, the unaudited interim financial statements furnished herein include all adjustments, all of which are of a normal recurring nature, necessary for a fair statement of the results for the interim period presented.

The preparation of financial statements in accordance with generally accepted accounting principles in the United States of America requires the use of estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities known to exist as of the date the financial statements are published, and the reported amounts of revenues and expenses during the reporting period.  Uncertainties with respect to such estimates and assumptions are inherent in the preparation of the Company's financial statements; accordingly, it is possible that the actual results could differ from these estimates and assumptions and could have a material effect on the reported amounts of the Company's financial position and results of operations.

Operating results for the three month period ended September 30, 2004 are not necessarily indicative of the results that may be expected for the year ending June 30, 2005.

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

This summary of significant accounting policies of FASC is presented to assist in understanding the Company's financial statements.  The financial statements and notes are representations of the Company's management, which is responsible for their integrity and objectivity.  These accounting policies conform to accounting principles generally accepted in the United States of America and have been consistently applied in the preparation of the financial statements.

Going ConcernThe accompanying financial statements have been prepared assuming that the Company will continue as a going concern. This basis of accounting contemplates the recovery of the Company's assets and the satisfaction of its liabilities in the normal course of operations.





F-5

-7-

---

FIRST AMERICAN SCIENTIFIC CORP.
Notes to Consolidated Financial Statements
September 30, 2004

______________________________________________________________________________________________

As shown in the accompanying financial statements, the Company has incurred an accumulated deficit of $11,267,209 through September 30, 2004 and has limited cash resources.  The Company recorded increased sales during the period ended September 30, 2004, but generated a net loss of $190,195.  These factors raise substantial doubt about the Company's ability to continue as a going concern.  Management plans to substantially increase sales through current channels and develop new sales opportunities.  Management has also established plans designed to increase the sales of the Company's products by continued research and development and combining technology with AGES as well as the joint venture with FASC (Malaysia) SBN.BHD.

Management intends to seek new capital from new equity securities offerings that will, if successful, provide funds needed to increase liquidity, fund internal growth and fully implement its business plan.  However, there is no assurance that the Company will raise the required capital.  If the Company is unable to raise the required capital, then it will assess its future business viability.

The financial statements do not include any adjustments relating to the recoverability and classification of recorded assets, or the amounts and classification of liabilities that might be necessary in the event the Company cannot continue in existence.

Revenue and Cost RecognitionRevenues from the sale of KDS machines are recognized when there is a sales contract, all terms of the contract have been completed, collectibility is reasonably assured and the products are delivered.  During the three months ended September 30, 2004, the Company sold one machine.

KDS machine costs include applicable direct material and labor costs and related indirect costs.  Changes in job performance, job conditions and estimated profitability may result in revisions to product costs, which are recognized in the period in which the revisions are determined.

ReclassificationsCertain prior year amounts in the accompanying financial statements have been reclassified to conform to the fiscal 2003 presentation.

NOTE 3 - COMMON STOCK

During the three months ended September 30, 2004, the Company issued 1,610,000 shares of common stock upon the exercise of options for compensation and other services with a fair market value of $89,240.  Additionally the Company sold 138,889 shares of common stock for cash of $10,000.





F-6

-8-

---

FIRST AMERICAN SCIENTIFIC CORP.
Notes to Consolidated Financial Statements
September 30, 2004

______________________________________________________________________________________________

NOTE 4 - STOCK OPTIONS

The Company's board of directors approved the First American Scientific Corp. 2004 and 2004A Non-qualified Stock Option Plan.  This plan allows the Company to distribute up to 20,000,000 shares of common stock options at a maximum share price of $0.05 to persons employed or associated with the Company.  This plan was not approved by the Company's security holders.

During the year ended June 30, 2004, the Company granted 1,610,000 options of which 1,610,000 were immediately exercised.

NOTE 5 - RELATED PARTIES

At September 30, 2004, the Company owes three of its shareholders $90,000 for accrued wages and $92,690 for loans made to the Company.

NOTE 6 - JOINT VENTURE

In July 2004, the Company signed an agreement to form a joint venture with two Malaysian companies to construct a fully operational palm waste processing plant to be 100% financed by the Malaysian partners.  Upon completion, the joint venture will be granted exclusive license for 21 years, to market the KDS equipment in Malaysia.  In addition to earning royalties from all KDS equipment sold in Malaysia, FASC will share equally in the operating profits of the joint venture.  A machine was purchased by the joint venture and shipped to Malaysia in August 2004.

NOTE 7 - CONTRACTS

On August 6, 2004, the Company entered into a agreement with The Waste and Resources Action Programme (hereinafter "WRAP") which is a UK Government funded program that supports research to improve markets for recycled materials and products in the UK.  WRAP intends to fund the cost of research and development (R&D), as WRAP determines appropriate, to determine the possibilities for the Company's KDS Technology and KDS Micronex Machine and ancillaries.  In addition, WRAP will conduct R&D to develop a production scale ancillary sludge separation system which can be used with the KDS Micronex Machine to reduce the costs and environmental impact of the sludge produced by the paper industry.  Under the terms of the agreement, WRAP will purchase a KDS Micronex Machine.  Also, WRAP will provide agreed funding in the amount of ^540,000 to be disbursed at WRAP's sole discretion for R&D purposes.





F-7

-9-

---

ITEM 2.  MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Liquidity and Capital Resources

We were incorporated April 12, 1995 as a development stage company. We are the owner of the KDS disintegration technology which is patented in the United States, Canada, UK, Europe, Mexico, Australia, and New Zealand. In addition to the core patent,  new patents for two new applications, one for the cryogenic freezing and shattering scrap rubber and one for separation of precious metals from mineral rock using our equipment have been granted. One other patent application for drying and recovery of fuel and clay from biomass has been submitted and is pending status. Further new registrations have been submitted in Japan and Malaysia. We have now reached proven commercial viability for several of our applications and have entered our marketing phase. To date, we have sold systems which are operating in Canada, the United States, Poland, and Malaysia, and have several new sales pending.

On September 30, 2004, we had current assets of $245,072 and current liabilities of $70,334 compared to the previous year on September 30, 2003 when we had $281,918 in current assets and $281,516 in current liabilities . Our working capital ratio on  September 30, 2004 was 3.48:1, which represents a significant improvement over last year when the working capital ratio was 1.0:1 on September 30, 2003.

Sustainable Development Technology Canada (SDTC) Funding

In October 2004, Sustainable Development Technology Canada (SDTC) awarded a CDN$600,000 research grant to AGES to construct and install a complete waste to energy KDS 3000 system at a Canadian pulp mill.  The approved location will be announced when agreements are finalized.

Waste Resources Action Program (WRAP) Research Funding

In September 2004, we signed an agreement wherein WRAP has agreed to provide funding to develop "value enhanced end-products" from the output of the KDS machine. WRAP has agreed to provide US$1,000,000 for the purchase and installation of one complete KDS system to be located at an industrial site in England. The fund will also pay for market research, scientific research, re-design and adaptation costs for the equipment and supplementary systems for industry-specific applications. Our engineering staff will manage the project which will run for approximately 18 months. The goals of the project are to demonstrate the KDS technology in a working environment, optimize ancillary equipment to improve its efficiency, and identify markets for recycled end products.

University of Tennessee  - USDA Funding

In July 2004, we were selected to participate with the University of Tennessee in a Biomass Research Initiative project funded by the US Dept of Agriculture. We were identified as a key industry partner for its history of developing novel size reduction and separation processes.  Our contribution to this research project is ongoing.





-10-

---

US Department of Energy - Phase II Grant

Although we were selected for a further US Dept of Energy (DOE) Phase II grant, that application did not proceed as we did not have a principle place of business in the United States. When this deficiency is remedied, we intend to reapply.

Accounting issues

We believe that the carrying value of our technology licenses, patents and manufacturing rights is fairly stated at cost less amortization using the straight line method over 15 years based upon the estimated present value of cash flows and our projections to sell at least two machines each year through 2006.  We have met this minimum sales target in fiscal year 2004, and we expect to exceed that target in fiscal year 2005 having already sold two systems so far this fiscal year.

Our auditors have issued a going concern statement because we do not have sufficient cash flow for us to maintain our operation for the next year.  Consequently, our management will have to seek additional capital from new equity securities offerings, loans, or other fund raising activities to maintain our operation should sales and receipt of receivables not materialize. In the short term, some relief has come from loans from our officers and by the deferment of payment of officers' salaries. This cannot be expected to continue indefinitely.

As of  September 30, 2004 there were 171,313,865 shares issued and outstanding.

Results of Operations - Quarter ending September 30, 2004

Revenue for the quarter ended September 30, 2004 was $147,646 compared to $453,655 for the same period last year. This quarter's revenue included the sale of one system to our joint venture corporation in Malaysia.  There were no equipment sales in the same period last year. three used to Vancouver Island Re-Cycling Ltd.  Full payment has been received and all machines delivered. The cost of the machines sold in 2003 was $150,000.  This is the impaired value of the three used machines.  The cost of the three machines sold in 2002 was $290,893.

Sales efforts are ongoing with several major projects in final stage of negotiation.  Subsequent to the date of these statements, in October 2004, we received a deposit from the Waste Resources Action Program (WRAP) of the UK for the purchase of one system which is currently being fabricated and scheduled for delivery in November 2004.

Net losses for the quarter ending September 30, 2004 were $188,042 or less than $0.01 per share compared to $388,617 for the same period last year. Efforts increase revenue and to control and reduce operating costs are continual.

We are participating in profits and royalties in three separate joint venture agreements as follows:





-11-

---

United Zeolite Products Ltd. Joint Venture - Halliburton contract

In February 2004, we became a 1/3rd partner, along with C2C Zeolite Corp and Zeotech Enviro Corp, in United Zeolite Products Ltd, a British Columbia company formed to build and operate a  specialty zeolite processing plant in Princeton, British Columbia. UZP has a $5,000,000 Cdn contract to supply of micronized zeolite to Halliburton Group Canada.  In August 2004,  Thelon Ventures Ltd., a Canadian company committed CDN$450,000 in cash to UZP as a condition to become a fourth equal partner in UZP, thereby by reducing each of the existing partners' equity position to 25% each of UZP's outstanding shares, but providing the balance of funds needed to complete the construction of the Princeton facility. As of the date of writing this report, Thelon has advanced $350,000 to UZP and the building construction is complete. KDS equipment was delivered in October 2004 and now is operational.  The first production runs for Halliburton are expected to begin in the November 2004.

Malaysian Joint Venture

In September 2004, we signed an agreement to form a new Malaysian company, FASC (Malaysia) Sdn. Bhd to construct a fully operational palm waste processing plant to be 100% financed by the Malaysian partners. Upon completion, FASC (Malaysia) Sdn. Bhd. will be granted exclusive license to market the KDS equipment in Malaysia.  In addition to earning royalties for all KDS equipment sold in Malaysia, we will share equally in the operating profits of  the joint venture and retain a 50 % ownership in FASC (Malaysia) Sdn. Bhd.  A machine was purchased by FASCMBS and shipped to Malaysia in August 2004.  Operations in Malaysia are expected to commence in November 2004.

Alternative Green Energy Systems Inc - Joint Venture

In February 2004, AGES received was granted a new 21 year exclusive license to design, manufacture and sell a large scale KDS machine for exclusive use in the pulp & paper industry in Canada, the USA and Europe.  We own 40% of AGES.  Plans for a new KDS Model 3000 have been finalized with the first  sale pending. The smaller Model 250 test machine remains at Atlantic Packaging Ltd.'s paper recycling facility in Whitby, Ontario for experimentation and demonstration purposes.

Other material contracts signed:

Mitsui Engineering & Shipbuilding Co. Ltd - Collaboration Agreement for Japan

In July 2004, we signed a collaboration with Mitsui Engineering and Shipbuilding Co. Ltd. (MES) wherein Mitsui will conduct a feasibility study into the marketability of the KDS Micronex System in Japan and evaluate the opportunity of venturing into a licensing agreement with us to introduce the KDS technology to the Japanese market.   It was further agreed that MES would undertake all necessary steps to file and protect our patents in Japan.  As of today's date, patent applications have been filed and the agreement has been extended until November 30, 2004 in order to allow time to finalize an exclusive marketing agreement.







-12-

---

Research and Development

We continue to focus on improving the KDS equipment's processing capacity and improve efficiencies for several different applications. We have determined that processing of softer materials such as biomass and pulp sludge currently represent the highest and best use for our technology and the most probable to generate sales. With the funding provided by SDTC, WRAP, and the USDA, research will continue into developing commercially viable applications for our technology.

Summary of Recent accomplishments



|Apr   2004 | Sale to Firma Codogni, Poland                        
|---------- | -----------------------------------------------------
|June  2004 | Sale to Atlas Mining, Utah                           
|July  2004 | USDA grant participation with University of Tennessee
|Sept 2004  | Sale to WRAP and grant awarded/sign funding agreement
|July  2004 | Sign Collaboration Agreement with Mitsui - Japan     
|Sept  2004 | Sale to FASC Malaysia/sign JV agreement              
|Oct  2004  | UZP/Halliburton project funding secured              
|Oct  2004  | SDTC grant awarded to AGES/sign funding agreement    
|Nov 2004   | Equipment commissioned at UZP Princeton site         

Inflation

Inflation has not been a factor effecting current operations, and is not expected to have any material effect on operations in the near future.

Foreign Operations

We rent office space in West Vancouver, British Columbia, Canada which serve as administrative and rent a sales offices and demonstration facility in Delta, British Columbia.  AGES rents office space in Montreal, Quebec.

ITEM 3. 	CONTROLS AND PROCEDURES

Quarterly evaluation of our disclosure controls and internal controls

Within the 90 days prior to the date of this report on Form 10-KSB, we evaluated the effectiveness of the design and operation of our "disclosure controls and procedures" (Disclosure Controls), and our "internal controls and procedures for financial reporting" (Internal Controls). This evaluation (the Controls Evaluation) was done under the supervision and with the participation of our management, including our chief executive officer (CEO) and chief financial officer (CFO). Our CEO performs the same functions as a principal executive officer and our CFO performs the same functions as a principal financial officer. Rules adopted by the SEC require that in this section of the quarterly report we present the conclusions of our CEO and our CFO about the effectiveness of our Disclosure Controls and Internal Controls based on and as of the date of the Controls Evaluation.





-13-

---

Disclosure controls and internal controls

Disclosure Controls are procedures that are designed with the objective of ensuring that information required to be disclosed in our reports filed under the Securities Exchange Act of 1934 (Exchange Act), such as this quarterly report, is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission's (SEC) rules and forms. Disclosure Controls are also designed with the objective of ensuring that such information is accumulated and communicated to our management, including the CEO and CFO, as appropriate to allow timely decisions regarding required disclosure. Internal Controls are procedures which are designed with the objective of providing reasonable assurance that (1) our transactions are properly authorized; (2) our assets are safeguarded against unauthorized or improper use; and (3) our transactions are properly recorded and reported, all to permit the preparation of our financial statements in conformity with generally accepted accounting principles.

Limitations on the Effectiveness of controls

Our management, including our CEO and CFO, confirm that the control systems are at the "reasonable assurance" level, however, management does not expect that our Disclosure Controls or our Internal Controls will prevent all error and all fraud as a control system. No matter how well conceived and operated, they cannot provide absolute assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within our company have been detected. These inherent limitations include the realities that judgments in decision-making can be faulty, and that breakdowns can occur because of simple error or mistake. Additionally, controls can be circumvented by the individual acts of some persons, by collusion of two or more people, or by management override of the control. The design of any system of controls also is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. However, upon discovery that the controls have become inadequate, they will be changed.

Scope of the Controls Evaluation

Our CEO/CFO evaluation of our Disclosure Controls and our Internal Controls included a review of the controls' objectives and design, the controls' implementation by us and the effect of the controls on the information generated for use in this quarterly report. In the course of the Controls Evaluation, we sought to identify data errors, controls problems or acts of fraud and to confirm that appropriate corrective action, including process improvements, were being undertaken. This type of evaluation will be done on a quarterly basis so that the conclusions concerning controls effectiveness can be reported in our Quarterly Reports on Form 10-QSB and Annual Report on Form 10-KSB. The overall goals of these various evaluation activities are to monitor our Disclosure Controls and our Internal Controls and to make modifications as necessary; our intent in this regard is that the Disclosure Controls and the Internal Controls will be maintained as dynamic systems that change (including with improvements and corrections) as conditions warrant.





-14-

---

Among other matters, we sought in our evaluation to determine whether there were any "significant deficiencies" or "material weaknesses" in our Internal Controls, or whether we had identified any acts of fraud involving personnel who have a significant role in our Internal Controls. This information was important both for the Controls Evaluation generally and because items 5 and 6 in the Section 302 Certifications of the CEO and CFO require that the CEO and CFO disclose that information to our Board of Directors Audit Committee and to our independent auditors and to report on related matters in this section of the quarterly report. In the professional auditing literature, "significant deficiencies" are referred to as "reportable conditions"; these are control issues that could have a significant adverse effect on the ability to record, process, summarize and report financial data in the financial statements. A "material weakness" is defined in the auditing literature as a particularly serious reportable condition where the internal control does not reduce to a relatively low level the risk that misstatements caused by error or fraud may occur in amounts that would be material in relation to the financial statements and not be detected within a timely period by employees in the normal course of performing their assigned functions. We also sought to deal with other controls matters in the Controls Evaluation, and in each case if a problem was identified, we considered what revision, improvement and/or correction to make in accord with our on-going procedures.

In accord with SEC requirements, our CEO and CFO note that, since the date of the Controls Evaluation to the date of this Quarterly Report, there have been no significant changes in Internal Controls or in other factors that could significantly affect Internal Controls, including any corrective actions with regard to significant deficiencies and material weaknesses.

Conclusions

Based upon the Controls Evaluation, our CEO and CFO have concluded that, our disclosure controls are effective to ensure that material information relating to us and our subsidiary is made known to management, including our CEO and CFO, particularly during the period when our periodic reports are being prepared. Our internal controls are effective to provide reasonable assurance that our financial statements are fairly presented in conformity with generally accepted accounting principles.

PART II.

ITEM 6. 	EXHIBITS AND REPORTS ON FORM 8-K



|(a) | Exhibit No. | Document                                                                                                                                                      
|--- | ----------- | --------------------------------------------------------------------------------------------------------------------------------------------------------------
|    | 31.1        | Certification of Principal Executive Officer pursuant to Rule 13a-15(a) and Rule 15d-15(a), promulgated under the Securities Exchange Act of 1934, as amended 
|    |             |                                                                                                                                                               
|    | 31.2        | Certification of Principal Financial Officer pursuant to Rule 13a-15(a) and Rule 15d-15(a), promulgated under the Securities Exchange Act of 1934, as amended.
|    |             |                                                                                                                                                               
|    | 32.1        | Certification Pursuant To 18 U.S.C. Section 1350, As Adopted Pursuant To Section 906 Of The Sarbanes-Oxley Act of 2002 (Chief Executive Officer)              
|    |             |                                                                                                                                                               
|    | 32.2        | Certification Pursuant To 18 U.S.C. Section 1350, As Adopted Pursuant To Section 906 Of The Sarbanes-Oxley Act of 2002 (Chief Financial Officer)              



-15-

---

SIGNATURES

In accordance with the requirements of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized on this 10th day of November, 2004.



| | FIRST AMERICAN SCIENTIFIC CORP.
(Registrant)
| | --------------------------------------------
| |                                             
| | By:                                         
| |                                             
| |                                             
| | By:                                         
| |                                             

































-16-

---